BioSpace News Archive

KalVista Pharmaceuticals, Inc. provided an operational update and released financial results for the fiscal second quarter ended October 31, 2019.

Bristol-Myers Squibb Company and Acceleron Pharma Inc. today announced the U.S. Food and Drug Administration’s Oncologic Drugs Advisory Committee will hold a review of Bristol-Myers Squibb’s supplemental Biologics License Application for the use of Reblozyl® in patients with myelodysplastic syndromes at its meeting on December 18, 2019.

The Company partners with Reified Capital, a provider of advanced artificial intelligence-focused technical advisory services to the private sector

DNARx, LLC announced the publication in Science Advances of data demonstrating the capabilities and efficacy of its pioneering HEDGES™ DNA-based, non-viral gene therapy delivery and expression platform.

Immunomedics, Inc. announced the resubmission of its Biologics License Application to the U.S. Food and Drug Administration seeking accelerated approval of sacituzumab govitecan for the treatment of patients with metastatic triple-negative breast cancer who have received at least two prior therapies for metastatic disease.

Lively Hearing Corp. announced it will donate $100 to the Hearing Loss Association of America for each pair of hearing aids it sells on Giving Tuesday with code GIVE100GET100.

BAMF Health purchases first uEXPLORER total body scanner and uPMR 790 PET/MR for clinical use in the United States [03-December-2019] HOUSTON , Dec. 3, 2019 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, announced today a global, strategic partnership with BAMF Health, an organization that is achieving AI-enable

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, is pleased to announce the completion of the first surgeries utilizing its new JOURNEY II Unicompartmental Knee (UK) System

Engages Tailfin to Support Brand Development Effort for Limited Launch in Tattoo Removal

Ikonopedia announced that Marshfield Clinic in Eau, Wisconsin, has selected the company’s structured breast reporting and risk assessment tools to help improve reporting efficiency, and optimize facility operations.